Prot #201656: NU 14S03: A Phase II Study of Pazopanib with Oral Topotecan in Patients with Metastatic and Non-resectable Soft Tissue and Bone Sarcomas

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date2/10/1512/31/21

Funding

  • GlaxoSmithKline LLC (Prot #201656)